Thursday, July 21, 2022
9:37 AM EST – DRI Healthcare Trust : Announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in pegcetacoplan for an upfront purchase price of $24.5 million U.S., with an option to increase its interest in pegcetacoplan in the future. DRI Healthcare Trust (T.DHT.UN) shares were unchanged at 9.01.
Stocks in Play: DRI Healthcare Trust, Thu, 21 Jul 2022 09:42:07 EST